Not finding it? Sign in to also search OpenAlex live.
-
Protocol, rationale and design of BE-PEOPLE (Bedaquiline enhanced exposure prophylaxis for LEprosy in the Comoros): a cluster randomized trial on effectiveness of rifampicin and bedaquiline as post-exposure prophylaxis of leprosy contacts
Younoussa Assoumani, Said Nourdine Samidine, Auke T. Bergeman, Alberto Piubello, Nissad Attoumani, Silahi Halifa Grillone, +14 more
22citations -
Validation of Fully Automated Robust Multicriterial Treatment Planning for Head and Neck Cancer IMPT2024 International Journal of Radiation Oncology*Biology*Physics article Medicine Radiation Therapy and Dosimetry Open access
Merle Huiskes, Wens Kong, Michelle Oud, Koen F. Crama, Coen R. N. Rasch, Sebastiaan Breedveld, +2 more
12citations -
Defining the pharmacokinetic/pharmacodynamic index of piperacillin/tazobactam within a hollow-fibre infection model to determine target attainment in intensive care patients2024 JAC-Antimicrobial Resistance article Medicine Antibiotics Pharmacokinetics and Efficacy Open access
Suzanne A M Wenker, Najla Alabdulkarim, John Readman, Elise M. A. Slob, Giovanni Satta, Shanom Ali, +3 more
1citations -
#1598 Implementation fidelity of a pharmacist-led intervention program to improve hyperphosphatemia in Dutch hemodialysis patients2025 Nephrology Dialysis Transplantation article Health Professions Health Policy Implementation Science Open access
Francisca Johanna van den Oever, Erwin C. Vasbinder, Yvonne C. Schrama, Teun van Gelder, Patricia M. L. A. van den Bemt, Jacqueline Geertruida Hugtenburg
0citations -
Direct probabilistic IMPT treatment planning with setup and range errors for neuro-oncological patients2026 Physics in Medicine and Biology article Physics and Astronomy Advanced Radiotherapy Techniques Open access
Jelte R. de Jong, Sebastiaan Breedveld, Steven Habraken, Mischa S. Hoogeman, Jenneke I. de Jong, Danny Lathouwers, +1 more
0citations -
NeflgArd Open-Label Extension: Efficacy and Safety of Nefecon in Patients with IgAN Who Completed the 2-Year Phase 3 Trial2024 Journal of the American Society of Nephrology article Medicine Renal Diseases and Glomerulopathies
Richard A. Lafayette, Jens Halkjaer Kristensen, Russell F Jones, Jürgen Floege, Vladimı́r Tesař, Hernán Trimarchi, +4 more
2citations -
Atacicept 150 mg Reduces Serum Gd-IgA1, a Biomarker Associated with Long-Term Outcomes in IgA Nephropathy (IgAN): 36W Results from the Ph2b ORIGIN Study2023 Journal of the American Society of Nephrology article Medicine Renal Diseases and Glomerulopathies
Jonathan Barratt, Bart Maes, Celia J. F. Lin, Xuelian Wei, Sean J. Barbour, Richard K. S. Phoon, +5 more
2citations -
Quantification of the endogenous growth hormone and prolactin lowering effects of a somatostatin-dopamine chimera using population PK/PD modeling2020 Journal of Pharmacokinetics and Pharmacodynamics article Medicine Growth Hormone and Insulin-like Growth Factors Open access
Michiel Joost van Esdonk, Jacobus Burggraaf, Marion Dehez, Piet H. van der Graaf, Jasper Stevens
3citations -
A Randomized Open-Label, Phase 3 Study to Evaluate Imetelstat Versus Best Available Therapy (BAT) in Patients with Intermediate-2 or High-Risk Myelofibrosis (MF) Refractory to Janus Kinase (JAK) Inhibitor
John O Mascarenhas, Claire N. Harrison, Jean‐Jacques Kiladjian, Ruben A. Mesa, Rami S. Komrokji, Steffen Koschmieder, +10 more
8citations -
Does Gender Influence the Effectiveness and Safety of Insulin Glargine 300 U/ml in Patients with Uncontrolled Type 2 Diabetes? Results from the REALI European Pooled Analysis
Pierre Gourdy, Riccardo C. Bonadonna, Nick Freemantle, Dı́dac Mauricio, Dirk Müller‐Wieland, Grégory Bigot, +3 more
6citations -
Inhaler use and their carbon footprint in Germany: a 10-year analysis (2013–2022)2025 BMJ Open Respiratory Research article Environmental Science Environmental Impact and Sustainability Open access
Sarah Blau, Martin Mücke, Michaela Hesse, Julia Sellin, Gabriele Gradl, Martin Schulz, +1 more
0citations